NASDAQ:PULM

Pulmatrix Stock Insider Trading

etoro logo Buy PULM
*Your capital is at risk
$1.29
-0.0300 (-2.27%)
At Close: Jun 03, 2026

Pulmatrix Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 4.15M and sold 111.2K PULM shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
0
Buy 4.15M shares
Sell 111.2K shares
84% Buy Activity
Negligible or No Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Jan 26, 2023
Buy
Stock Option (Right to Buy)
A-Award
Siegert Michelle
Vice President, Finance
CEO / President 9 900
Value: $0
Jan 26, 2023
Buy
Stock Option (Right to Buy)
A-Award
Wasilewski Margaret
Chief Medical Officer
Officer 11 400
Value: $0
Jan 26, 2023
Buy
Stock Option (Right to Buy)
A-Award
Raad Teofilo David
Chief Executive Officer
CEO / President 34 900
Value: $0
Jan 26, 2023
Buy
Stock Option (Right to Buy)
A-Award
Bazemore Todd
Director
Director 1 700
Value: $0
Jan 26, 2023
Buy
Stock Option (Right to Buy)
A-Award
Higgins Michael J
Director
Director 2 436
Value: $0
Jan 26, 2023
Buy
Stock Option (Right to Buy)
A-Award
Cabell Christopher
Director
Director 1 700
Value: $0
Jan 26, 2023
Buy
Stock Option (Right to Buy)
A-Award
Varadan Anand
Director
Director 1 700
Value: $0
Jan 26, 2023
Buy
Stock Option (Right to Buy)
A-Award
Batycky Richard P.
Director
Director 1 700
Value: $0
Jan 26, 2023
Buy
Stock Option (Right to Buy)
A-Award
Batycky Richard P.
Director
Director 1 700
Value: $0
Jan 26, 2023
Buy
Stock Option (Right to Buy)
A-Award
Varadan Anand
Director
Director 1 700
Value: $0
Jan 26, 2023
Buy
Stock Option (Right to Buy)
A-Award
Cabell Christopher
Director
Director 1 700
Value: $0
Jan 26, 2023
Buy
Stock Option (Right to Buy)
A-Award
Higgins Michael J
Director
Director 2 436
Value: $0
Jan 26, 2023
Buy
Stock Option (Right to Buy)
A-Award
Bazemore Todd
Director
Director 1 700
Value: $0
Jan 26, 2023
Buy
Stock Option (Right to Buy)
A-Award
Raad Teofilo David
Chief Executive Officer
CEO / President 34 900
Value: $0
Jan 26, 2023
Buy
Stock Option (Right to Buy)
A-Award
Wasilewski Margaret
Chief Medical Officer
Officer 11 400
Value: $0
Jan 26, 2023
Buy
Stock Option (Right to Buy)
A-Award
Siegert Michelle
Vice President, Finance
CEO / President 9 900
Value: $0
Apr 18, 2022
Buy
Common Stock
J-Other
Ludlum Peter
Officer
Officer 0
Value: $0
Apr 18, 2022
Buy
Common Stock
J-Other
Ludlum Peter
Officer
Officer 0
Value: $0
Mar 01, 2022
Buy
Stock Option (Right to Buy)
A-Award
Wasilewski Margaret
Chief Medical Officer
Officer 21 060
Value: $0
Mar 01, 2022
Buy
Common Stock
J-Other
Wasilewski Margaret
Officer
Officer 0
Value: $0
Mar 01, 2022
Buy
Common Stock
J-Other
Wasilewski Margaret
Officer
Officer 0
Value: $0
Mar 01, 2022
Buy
Stock Option (Right to Buy)
A-Award
Wasilewski Margaret
Chief Medical Officer
Officer 21 060
Value: $0
Jan 27, 2022
Buy
Stock Option (Right to Buy)
A-Award
Higgins Michael J
Director
Director 36 833
Value: $13.6K
Jan 27, 2022
Buy
Stock Option (Right to Buy)
A-Award
Batycky Richard P.
Director
Director 22 100
Value: $8K
Jan 27, 2022
Buy
Stock Option (Right to Buy)
A-Award
Cabell Christopher
Director
Director 22 100
Value: $8K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT PULMATRIX
Pulmatrix
Pulmatrix, Inc., a clinical stage biotechnology company, discovers and develops inhaled therapies to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company focuses on developing products based on its inhaled small particles easily respirable and emitted (iSPERSE) technology, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE